Dopamine System Stabilizers, Aripiprazole, and the Next Generation of Antipsychotics, Part 1¶
Stahl. (2001). Dopamine System Stabilizers, Aripiprazole, and the Next Generation of Antipsychotics, Part 1: "Goldilocks" Actions at Dopamine Receptors. The Journal of Clinical Psychiatry.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Domain-specific¶
- Partial Agonist
- This "dopamine stabilizer" behavior contributes to its efficacy with a lower burden of the movement side effects that pure D2 blockade produces
This sourceThe account that non-specific blockade of nigrostriatal D2 receptors produces the extrapyramidal motor side effects of conventional antipsychotics.
Supported in partVerified against the publisher's abstract
“when D2 receptors in the nigrostriatal dopamine pathway are also blocked, a penalty is paid in motor side effects, namely extrapyramidal reactions, pseudoparkinsonism, and ultimately, tardive dyskinesia.”
- This "dopamine stabilizer" behavior contributes to its efficacy with a lower burden of the movement side effects that pure D2 blockade produces
Verification¶
Does it exist? Not checked yet. This work's DOI is recorded above but has not been resolved against an external catalogue, so nothing here confirms the work exists.
Does it back the claim? Read against the text for 1 of 1 citation: 1 supported in part. Each verdict is shown under its citation below, with what in the work backs the sentence.
Support is checked per citation rather than per work — the same source can be cited soundly in one article and wrongly in another. Per-citation recording began recently, so a citation with no recorded check is a gap in the record rather than evidence it went unchecked.
See how references were verified.
Registry ID ref:eed332308d24 · see in the full table